Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.
David James PinatoAntonio D'AlessioClaudia Angela Maria FulgenziAlexandra Emilia SchlaakCiro CelsaSaskia KillmerJesus Miguens BlancoCaroline WardCharalampos-Vlasios StikasOpenshaw M RNicole AcutiGeorgios NteliopoulosCristina BalcellsHector C KeunRobert D GoldinPaul J RossAlessio CortelliniRobert ThomasAnna Mary YoungNathan P DanckertPaul TaitJulian R MarchesiBertram BengschRohini SharmaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
TACE plus pembrolizumab was tolerable with no evidence of synergistic toxicity, encouraging further clinical development of immunotherapy alongside TACE.